ESG

Meren Energy's upcoming Q1 2026 results will be scrutinized for its performance in Africa's deepwater projects amidst soaring oil prices and strategic shifts.

A new AI voice agent from Zibu promises to solve after-hours communication woes, reduce missed appointments, and alleviate doctor burnout. But can it stand out?

The trust advances major Toronto developments and improves its debt position, signaling a long-term strategy amid a challenging real estate market.

As Spruce Power preps its Q1 results, investors watch to see how the firm is navigating the end of key tax credits and rising competition.

Enabled Talent launches a fellowship with a radical promise: it won't end until participants secure a job, bridging the gap from readiness to results.

A landmark partnership between Anthem and Ohio chambers marks 10 years, covering 94,000 people and reshaping affordable healthcare for small employers.

Valion Bio's new General Counsel, a rare blend of scientist and lawyer, is poised to navigate its radiation drug through the FDA's complex Animal Rule.

CTIBIOTECH brings revolutionary 3D human tissue printing to 'Cellicon Valley,' aiming to slash drug failures and accelerate personalized medicine.

A pioneering project offers a new model for tackling homelessness, combining private innovation with community expertise to provide dignity and stability.

The Asian Heritage Foundation goes national, partnering with the NCAC to unite communities and intensify the fight against anti-Asian hate across Canada.

Chinese beverage leader Walovi inks deals in 10 nations, leveraging health trends and a bold strategy to expand its plant-based empire worldwide.

A novel medical food for IBS shows remarkable efficacy in new studies, exceeding FDA benchmarks for pain relief and solving the long-standing issue of taste.

As enterprises move from AI experimentation to execution, the focus is shifting to a critical, overlooked element: the data. Here's why.

Wisk Aero's second Gen 6 eVTOL has taken flight, a move set to fast-track its autonomous flight program and intensify the race for certified air taxis.

A major investment in natural killer cell immunotherapy aims to revolutionize treatment for Canada's most fatal women's cancer after decades of stagnation.

Morningstar's investment chief joins a health AI firm, signaling a new era where financial modeling principles could unlock preventative wellness for millions.

LANGLARA, a new Lantus biosimilar, gains FDA approval, promising more affordable diabetes care. But it faces a tough fight in a competitive market.

The new Gibco CTS DynaXS bioreactor aims to unlock scalable production, making life-saving cell therapies more accessible and affordable for patients.

One in five mothers face perinatal mental health disorders, but most never get help. An inside look at the systemic failures and the fight for a lifeline.

Scott Drennan takes the helm at Otto Aerospace, tasked with turning the visionary, ultra-efficient Phantom 3500 jet from concept to certified reality.